Alaska Alliance for Community Engagement Phase II: Partnership for Action Toward Health

Part of paid clinical trials in Fairbanks, Alaska.

Sponsor
University of Alaska Fairbanks
Study ID
NCT07801989
Phase
PHASE1
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Adolescent Health
  • Caridovascular Disease
  • Chronic Disease
  • Mental Health
  • Stress

Eligibility Criteria

Sex
ALL
Age
12 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Tools for Arctic Health Promotion — BEHAVIORAL
    The TAHP intervention will utilize a valid measure of rural AN community-level protective factors (Allen, et al., 2025), and an evidence-based toolkit containing strategies proven to increase mental health and well-being in rural AN communities (Allen, Charles, et al., 2023). A formalized community engaged process will generate new intervention activities that integrate cutting-edge science to address local health priorities.

Study Details

The AK ACE-PATH Phase II study aims to pilot and implement a novel intervention, Tools for Arctic Health Promotion (TAHP), to address Alaska Native (AN) community priorities related to local health and community-level resilience.

Key Dates

First listed
Sep 3, 2026
Start date
Sep 21, 2026
Status verified
Aug 2026
Primary completion
Oct 31, 2028
Completion
Apr 30, 2029

Study Design

Enrollment
360 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION

Arms

  • Experimental: Enrollment in TAHP
    The study will enroll 360 participants from four unique community settings to receive the TAHP intervention. The study design will make use of a dynamic wait-listed design (DWLD) with 360 participants assessed with behavioral and community-level measures at four time points: baseline (B), intervention midpoint (T1), Intervention end (T2) and 12-month follow-up (T3).

Primary Outcome Measure

Perceived Stress Scale Questionnaire will measure individual-level indicators of stress that we hypothesize will decrease over time with intervention participation [ Time Frame: Day 1 (baseline), 4 months (T1), 8 months (T2) and at 20 months (T3) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Alaska FairbanksFairbanksAlaska99775
Maria Stejskal
[email protected]
907-474-6230

Find similar trials in Fairbanks, AK

By research site
University of Alaska Fairbanks· Fairbanks, AK

Related Studies